Literature DB >> 12686331

Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.

Sunil V Rao1, E Magnus Ohman, Christopher B Granger, Paul W Armstrong, W Brian Gibler, Robert H Christenson, Vic Hasselblad, Amanda Stebbins, Steven McNulty, L Kristin Newby.   

Abstract

The risk of death or recurrent myocardial infarction (MI) in patients with chest pain and baseline isolated troponin elevation is unclear. To determine the early and short-term risk of death or MI associated with isolated troponin elevation across a spectrum of chest pain syndromes, we used baseline creatine kinase (CK)-MB and troponin data from the Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network (PARAGON) B troponin substudy, the Global Utilization of Strategies To Open Occluded Coronary Arteries (GUSTO) IIa troponin substudy, and the Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) study. Patients were grouped into 1 of 4 categories based on marker status (troponin-positive/CK-MB-positive, troponin-positive/CK-MB-negative, troponin-negative/CK-MB-positive, or troponin-negative/CK-MB-negative). The adjusted odds of death or MI occurring at 24 hours and 30 days was assessed by baseline marker status using multivariable logistic regression, with the group negative for both markers used as the reference. Patients who were positive for both markers had the highest odds of the 24-hour and 30-day end point. The adjusted odds of the 30-day end point for patients with isolated troponin elevation were 1.3 (95% confidence interval 0.7 to 2.3) and 4.8 (95% confidence interval 1.4 to 16.0) for high- and low-risk patients, respectively. The risk for 24-hour and 30-day death or MI with isolated positive CK-MB results was lower than with isolated positive troponin results, and it was not significantly greater than if the 2 markers were negative. For patients with high- and low-risk chest pain, baseline troponin elevation without CK-MB elevation was associated with increased risk for early and short-term adverse outcomes. This suggests that these patients should be admitted to the hospital and monitored in either an intensive care or step-down unit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686331     DOI: 10.1016/s0002-9149(03)00107-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.

Authors:  Ankie Amos; L Kristin Newby
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

Review 2.  Prevention of stroke following transient ischemic attack.

Authors:  Sharon Poisson; S Claiborne Johnston
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

3.  The clinical significance of cardiac troponins in medical practice.

Authors:  Mohammed A Al-Otaiby; Hussein S Al-Amri; Abdulrahman M Al-Moghairi
Journal:  J Saudi Heart Assoc       Date:  2010-10-20

4.  Biochemical markers of myocardial injury.

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2007-03

5.  Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.

Authors:  Siyu Guo; Jiarui Wu; Wei Zhou; Xinkui Liu; Yingying Liu; Jingyuan Zhang; Shanshan Jia; Jialin Li; Haojia Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

6.  Detected troponin elevation is associated with high early mortality after lung resection for cancer.

Authors:  Eric Lim; Li Li Choy; Lydia Flaks; Shafi Mussa; Fillip Van Tornout; Marc Van Leuven; G Wyn Parry
Journal:  J Cardiothorac Surg       Date:  2006-10-23       Impact factor: 1.637

7.  CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction.

Authors:  Govigerel Bayarsaikhan; Delger Bayarsaikhan; Pyung Chun Oh; Woong Chol Kang; Bonghee Lee
Journal:  Antioxidants (Basel)       Date:  2021-03-11

8.  Transcranial Doppler ultrasonography predicts cardiovascular events after TIA.

Authors:  Katrin Holzer; Suwad Sadikovic; Lorena Esposito; Angelina Bockelbrink; Dirk Sander; Bernhard Hemmer; Holger Poppert
Journal:  BMC Med Imaging       Date:  2009-07-30       Impact factor: 1.930

9.  Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats.

Authors:  Shafique Ahmad; Bibhu Prasad Panda; Mohammad Fahim; Neha Dhyani; Kiran Dubey
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.